Overview

A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001)

Status:
Terminated
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the treatment effect of three doses of the I-vation TA implant (MK0140) in diabetic patients with clinically significant macular edema.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide